Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapFalling Star
    All News

    Brief: Genmab Says Johnson & Johnson Will Not Exercise Option For Hexabody-Cd38 License

    Picture of Genmab A/S logoGenmab A/S
    10/03/2025 17:08
    March 10 (Reuters) - Genmab A/S GMAB.CO:

GENMAB ANNOUNCES JOHNSON & JOHNSON DECISION REGARDING HEXABODY®-CD38

GENMAB A/S - JOHNSON & JOHNSON WILL NOT EXERCISE OPTION FOR HEXABODY-CD38 LICENSE

GENMAB A/S - WILL NOT PURSUE FURTHER CLINICAL DEVELOPMENT OF HEXABODY-CD38

GENMAB A/S - NEWS DOES NOT IMPACT GENMAB'S 2025 FINANCIAL GUIDANCE

Source text: ID:nGNX9tBt34

Further company coverage: GMAB.CO

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Genmab A/S

    See all news